Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07708493 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With Normal Weight or Overweight

StatusActive, Not Recruiting
PhasePhase 1
Started2026-08-24
View on ClinicalTrials.gov ↗

Amendment history

2026-09-04
notable
Study Status, Contacts/Locations v2
Enrollment closed, study ongoing
Recruitment opened
Study sites0→1
2026-08-18
minor
Study Status v1
Start date2026-07-29→2026-08-24
2026-07-13
minor
Original filing
The main objectives of this trial are: To assess the mass balance (total recovery of \[14C\]-radioactivity) in urine, faeces, and expired air after a single subcutaneous dose of BI 3034701 (C-14) in healthy male trial participants.
Trial Details
NCT Number NCT07708493
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 8 participants
Start Date 2026-08-24
Primary Completion 2026-10-14 (estimated)
Study Completion 2026-10-14 (estimated)
Updated on ClinicalTrials.gov 2026-09-30